Meningitis Outbreak in Kent -  Patient Information

 

Forest Edge Practice is aware of an ongoing outbreak of invasive meningococcal disease (group B) affecting young people in the Canterbury/Kent area. We are following UK Health Security Agency (UKHSA) guidance closely.

What is meningitis?

Meningitis is an infection of the lining of the brain and spinal cord. It can progress rapidly and may be life-threatening, particularly in bacterial cases such as meningococcal disease.

 

Current situation (Kent outbreak)

  • Cases are mainly linked to students and young people in Canterbury
  • Confirmed as meningococcal group B infection
  • Severe illness has been reported, including deaths 

A targeted vaccination programme is being introduced for high-risk groups.

 

Symptoms to watch for

  • Fever, headache, neck stiffness
  • Sensitivity to light
  • Vomiting, confusion
  • Cold hands/feet, limb pain
  • Drowsiness or seizures
 

Emergency signs:

  • Non-fading rash
  • Unresponsiveness
  • Breathing difficulty

Call 999 immediately if these occur

 

Who is eligible for meningitis vaccination (current guidance)

Routine NHS eligibility (already in place)

 These groups are routinely offered meningococcal vaccines:

  • Babies – MenB vaccine (as part of childhood schedule)
  • Teenagers (Year 9–10 / age 13–15) – MenACWY vaccine
  • University entrants (up to age 25) – MenACWY if not already vaccinated
  • Clinical risk groups (e.g. asplenia, complement disorders)

Additional eligibility during this outbreak

According to UKHSA guidance:

  • Students living in halls of residence at the University of Kent (Canterbury campus)
  • Staff living or working in affected halls
  • Individuals identified as close contacts of confirmed cases

These groups may be offered targeted vaccination and/or antibiotic prophylaxis.

Eligibility is being actively defined and updated by UKHSA, and individuals will usually be contacted directly.

Who is not currently eligible on the NHS (unless high risk)

  • General public without exposure risk
  • Adults outside routine vaccination groups
  • Children already fully vaccinated and not identified as contacts
 

Vaccine types and dosing (simplified guide)

MenB vaccine (Bexsero)

Used for Group B meningococcus (current outbreak strain)

  • Infants (routine schedule):2 doses + booster
  • 1 year and over: 2 doses (at least 1 month apart)
  • Adults: 2 doses (1 month apart)

MenACWY vaccine

Protects against groups A, C, W, Y (not B)

  • Teenagers / adults: Single dose
 

Can the vaccine be done privately?

Yes.

  • MenB vaccination is available privately for those not eligible on the NHS
  • Typically offered by:
    • Private GP clinics
    • Travel clinics
    • Some pharmacies

Cost (approximate):

  • £100–£150 per dose
  • Full course usually requires 2 doses

Availability may vary locally due to increased demand during the outbreak.

 

Important: Antibiotics for close contacts

Close contacts of confirmed cases may be offered preventative antibiotics (e.g. ciprofloxacin single dose) regardless of vaccination status.

 

When to seek help

  • Emergency symptoms → Call 999
  • Urgent concerns → NHS 111 or GP
  • If contacted by UKHSA → follow instructions promptly
 

Prevention advice

  • Ensure vaccinations are up to date
  • Avoid sharing drinks/utensils
  • Practice good respiratory hygiene
 

Reassurance

Meningitis remains rare, and early treatment is highly effective. Public health teams are actively managing this outbreak and contacting those at risk.

 

Further information

  • Learn about Meningitis
  • UKHSA guidance: see outbreak alert document
  • Meningitis charities: Meningitis Now / Meningitis Research Foundation

If you are concerned about symptoms, do not delay seeking medical advice.

Forest Edge Practice

Your health and safety remain our priority.

Published: Mar 20, 2026